Read + Share
Amedeo Smart
Independent Medical Education
Fan Q, Wu G, Chen M, Luo G, et al. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats. Eur J Pharmacol 2023 Dec 27:176278. doi: 10.1016/j.ejphar.2023.176278.PMID: 38158116
Email
LinkedIn
Facebook
Twitter
Privacy Policy